| Document Type
|
:
|
BL
|
| Record Number
|
:
|
976608
|
| Doc. No
|
:
|
b730978
|
| Main Entry
|
:
|
National Research Council (U.S.)., Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials.
|
| Title & Author
|
:
|
Treating infectious diseases in a microbial world : : report of two workshops on novel antimicrobial therapeutics /\ Committee on New Directions in the Study of Antimicrobial Therapeutics: New Classes of Antimicrobials ; Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation, Board on Life Sciences, Division on Earth and Life Sciences, National Research Council of the National Academies.
|
| Publication Statement
|
:
|
Washington, D.C. :: National Academies Press,, ©2006.
|
| Page. NO
|
:
|
1 online resource (x, 92 pages) :: illustrations, charts
|
| ISBN
|
:
|
0309654904
|
|
|
:
|
: 1280310057
|
|
|
:
|
: 661031005X
|
|
|
:
|
: 9780309654906
|
|
|
:
|
: 9781280310058
|
|
|
:
|
: 9786610310050
|
|
|
:
|
0309100569
|
|
|
:
|
9780309100564
|
| Bibliographies/Indexes
|
:
|
Includes bibliographical references.
|
| Contents
|
:
|
Challenges for the Development of New Antimicrobials: Rethinking the Approaches: Report of a Workshop -- Promising Approaches to the Development of Immunomodulation for the Treatment of Infectious Diseases: Report of a Workshop.
|
| Abstract
|
:
|
Humans coexist with millions of harmless microorganisms, but emerging diseases, resistance to antibiotics, and the threat of bioterrorism are forcing scientists to look for new ways to confront the microbes that do pose a danger. This report identifies innovative approaches to the development of antimicrobial drugs and vaccines based on a greater understanding of how the human immune system interacts with both good and bad microbes. The report concludes that the development of a single superdrug to fight all infectious agents is unrealistic.
|
| Subject
|
:
|
Anti-infective agents-- Therapeutic use, Congresses.
|
| Subject
|
:
|
Communicable diseases-- Treatment, Congresses.
|
| Subject
|
:
|
Infection-- Treatment, Congresses.
|
| Subject
|
:
|
Anti-Bacterial Agents-- therapeutic use.
|
| Subject
|
:
|
Anti-Infective Agents-- therapeutic use.
|
| Subject
|
:
|
Anti-Infective Agents.
|
| Subject
|
:
|
Bacterial Infections and Mycoses
|
| Subject
|
:
|
Bacterial Infections.
|
| Subject
|
:
|
Chemical Actions and Uses
|
| Subject
|
:
|
Chemicals and Drugs
|
| Subject
|
:
|
Communicable Diseases-- drug therapy.
|
| Subject
|
:
|
Disease.
|
| Subject
|
:
|
Immune System-- physiopathology.
|
| Subject
|
:
|
Immunologic Factors-- therapeutic use.
|
| Subject
|
:
|
Infections.
|
| Subject
|
:
|
Pharmacologic Actions
|
| Subject
|
:
|
Therapeutic Uses
|
| Subject
|
:
|
Anti-infective agents-- Therapeutic use.
|
| Subject
|
:
|
Communicable diseases-- Treatment.
|
| Subject
|
:
|
Health Biological Sciences.
|
| Subject
|
:
|
Infection-- Treatment.
|
| Subject
|
:
|
MEDICAL-- Pharmacology.
|
| Subject
|
:
|
Pharmacy, Therapeutics, Pharmacology.
|
| Dewey Classification
|
:
|
615.329
|
| LC Classification
|
:
|
RM265.2.N38 2006eb
|
| NLM classification
|
:
|
QV 250N277t 2006
|
| Added Entry
|
:
|
National Research Council (U.S.)., Committee on New Directions in the Study of Antimicrobial Therapeutics: Immunomodulation.
|